Intriguing discussion and interview with Jim Smeeding, MBA president of JestaRx Group and Elie Khalife CEO of KeyCentrix about the impact of Medical Marijuana on therapies for patients and multiple diseases states where Specialty Pharmacy is focused. 
Introductions - Jim Smeeding's background & founding meember of the National Association of Specialty Pharmacies 
Overview of Medical Marijuana today

Ability and interest of medical professionals to participate
Physicians /MD’s qualifying patient as medically eligible 
Paucity of Data and legislative indications without science 
Interest by pharmacists to participate in Medical Marijuana as a medical alternative
VA data - reduced use of opioids when Medical Marijuana is offered

Regulatory Issues nationwide
Globally - Uruguay – Colombia, Israel and ICRS 
State by State - 
Medical Marijuana role in the opiod crisis 

Intriguing discussion and interview with&nbsp;<a href="https://www.linkedin.com/in/jim-smeeding-mba-3b51a4/">Jim Smeeding, MBA</a> president of <a href="https://jestarx.com/about-jestarx/">JestaRx Group</a>&nbsp;and Elie Khalife CEO of KeyCentrix about the impact of Medical Marijuana on therapies for patients and multiple diseases states where Specialty Pharmacy is focused.&nbsp;
<ul>
<li>Introductions - Jim Smeeding's background &amp; founding meember of the National Association of Specialty Pharmacies&nbsp;</li>
<li>Overview of Medical Marijuana today
<ul>
<li>Ability and interest of medical professionals to participate</li>
<li>Physicians /MD&rsquo;s qualifying patient as medically eligible&nbsp;</li>
<li>Paucity of Data and legislative indications without science&nbsp;</li>
<li>Interest by pharmacists to participate in Medical Marijuana as a medical alternative</li>
</ul>
<ul>
<li>VA data - reduced use of opioids when Medical Marijuana is offered</li>
</ul>
</li>
<li>
<ul>
<li>Regulatory Issues nationwide</li>
<li>Globally - Uruguay &ndash; Colombia, Israel and ICRS&nbsp;</li>
<li>State by State -&nbsp;</li>
<li>Medical Marijuana role in the opiod crisis&nbsp;</li>
</ul>
</li>
</ul>

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.

The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.

The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.

The definition of “Innovation” is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare & the PPN is the Pharmacist's biggest fan. 

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.
The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.
The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.
The definition of &ldquo;Innovation&rdquo; is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare &amp; the PPN is the Pharmacist's biggest fan.&nbsp;

Pharmacy Podcast Network

What is medical marijuana?

The term medical marijuana refers to using the whole, unprocessed marijuana plant or its basic extracts to treat symptoms of illness and other conditions. The U.S. Food and Drug Administration (FDA) has not recognized or approved the marijuana plant as medicine.

However, scientific study of the chemicals in marijuana, called cannabinoids, has led to two FDA-approved medications that contain cannabinoid chemicals in pill form. Continued research may lead to more medications.

Because the marijuana plant contains chemicals that may help treat a range of illnesses and symptoms, many people argue that it should be legal for medical purposes. In fact, a growing number of states have legalized marijuana for medical use.

Cannabidiol (CBD) has been recently covered in the media, and you may have even seen it as an add-in booster to your post-workout smoothie or morning coffee. What exactly is CBD? Why is it suddenly so popular?

How is cannabidiol different from marijuana?

CBD stands for cannabidiol. It is the second most prevalent of the active ingredients of cannabis (marijuana). While CBD is an essential component of medical marijuana, it is derived directly from the hemp plant, which is a cousin of the marijuana plant. While CBD is a component of marijuana (one of hundreds), by itself it does not cause a “high.” According to a report from the World Health Organization, “In humans, CBD exhibits no effects indicative of any abuse or dependence potential…. To date, there is no evidence of public health related problems associated with the use of pure CBD.”

What is medical marijuana?
The term&nbsp;medical marijuana&nbsp;refers to using the whole, unprocessed marijuana plant or its basic extracts to treat symptoms of illness and other conditions. The U.S. Food and Drug Administration (FDA) has not recognized or approved the marijuana plant as medicine.
However, scientific study of the chemicals in marijuana, called&nbsp;cannabinoids, has led to two FDA-approved medications that contain cannabinoid chemicals in pill form. Continued research may lead to more medications.
Because the marijuana plant contains chemicals that may help treat a range of illnesses and symptoms, many people argue that it should be legal for medical purposes. In fact, a growing number of states have legalized marijuana for medical use.
Cannabidiol (CBD) has been recently covered in the media, and you may have even seen it as an add-in booster to your post-workout smoothie or morning coffee. What exactly is CBD? Why is it suddenly so popular?
How is cannabidiol different from marijuana?
<a href="https://www.health.harvard.edu/staying-healthy/cbd-products-are-everywhere-but-do-they-work">CBD</a>&nbsp;stands for cannabidiol. It is the second most prevalent of the active ingredients of cannabis (marijuana). While CBD is an essential component of&nbsp;<a href="https://www.health.harvard.edu/blog/medical-marijuana-2018011513085">medical marijuana</a>, it is derived directly from the hemp plant, which is a cousin of the marijuana plant. While CBD is a component of marijuana (one of hundreds), by itself it does not cause a &ldquo;high.&rdquo; According to a report from the&nbsp;<a href="http://www.who.int/medicines/access/controlled-substances/5.2_CBD.pdf">World Health Organization</a>, &ldquo;In humans, CBD exhibits no effects indicative of any abuse or dependence potential&hellip;. To date, there is no evidence of public health related problems associated with the use of pure CBD.&rdquo;

CRx Podcast

The Pharmacy Podcast Network (PPN) is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading pharmacy care. We are proud to have gathered more than 40 different hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and the patients we serve.

The PPN started in March of 2009 and has generated more than 2,000+ episodes publishing 6 to 7 days per week with over 140K+ listeners per month. The PPN was the first podcast to release continuing education for pharmacists in 2019 and was voted 'Healthcare Podcast of the Year' in 2022 by the Healthcare and IT Marketing Community (HITMC).

We're exploring the profession of pharmacy through audio. Pharmacists are our favorite Providers.

Pharmacy Podcast Network™ is a registered trademark

The Pharmacy Podcast Network (PPN) is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading pharmacy care. We are proud to have gathered more than 40 different hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and the patients we serve. The PPN started in March of 2009 and has generated more than 2,000+ episodes publishing 6 to 7 days per week with over 140K+ listeners per month. The PPN was the first podcast to release continuing education for pharmacists in 2019 and was voted 'Healthcare Podcast of the Year' in 2022 by the Healthcare and IT Marketing Community (HITMC). We're exploring the profession of pharmacy through audio. Pharmacists are our favorite Providers.
Pharmacy Podcast Network&trade; is a registered trademark

Intriguing discussion and interview with Jim Smeeding, MBA president of JestaRx Group and Elie Khalife CEO of KeyCentrix about the impact of Medical Marijuana on therapies for patients and multiple diseases states where Specialty Pharmacy is...

Medical Marijuana & Specialty Pharmacy (Part One) - PPN Episode 521

Each day, more than 130 people die from opioid overdoses.

Opioids are a class of drugs that include prescription pain relievers like oxycodone. They also include illegal drugs like heroin. In 2019, 1.6 million Americans had an opioid addiction. This is also known as opioid use disorder. Yet effective medications—like buprenorphine, methadone, and naltrexone—are prescribed to only a fraction of people with opioid use disorder. Patients often receive such medications in an opioid treatment program. Methadone, for example, can only be given in a certified treatment program. Primary care physicians can apply for a waiver to prescribe buprenorphine. However, less than 10% of U.S. primary care providers have a buprenorphine waiver. Given the limited number of patients that each physician can treat, involving pharmacists in opioid treatment may improve access.

The Doctor Patient Forum’s Mission Statement is to advocate, educate, and defend the rights of patients, to protect all providers (including prescribers and pharmacists) who tirelessly work to treat their patients, and to bring awareness to the general public regarding restrictions upon medical providers. We are fighting for a return to individualized patient care instead of using guidelines and laws based on little evidence using arbitrary thresholds. Contrary to what has been said, we are not “industry funded.” We haven’t taken any money from pharma. We are not being paid to promote opioids. We are simply chronic pain and illness patients who are fighting as hard as we can to effect change in this broken system where the patient’s voice is non-existent.

For part 4 of the series, we're honored to have Ms. Bev Schechtman. Ms. Schectman is one of the founding members of Don’t Punish Pain Rally and is the VP of The Doctor Patient Forum. She grew up in northern New Jersey, and has lived in the Raleigh area in North Carolina since 2009. Bev has been married to Randy for 18 years, and has two teenage daughters, Emma, 17, and Livvy,13. She also has a 3-year-old Aussidoodle, Griffin.

Bev has been living with Crohn’s Disease and Psoriatic Arthritis for over two decades. She first contacted Claudia Merandi after being denied opioid medication while hospitalized for kidney stones in 2017.She was denied due to being a survivor of childhood sexual abuse. Bev is a passionate advocate for people with chronic pain and illness as well as those who have PTSD/ survived sexual assault/abuse. Bev has her B.A. in Psychology and hopes to get her M.S.W. in the near future. Bev is a voracious reader and researcher. She is passionate about understanding why pain patients are being mistreated so she can educate other patients and empower them to fight back. Bev hopes her advocacy work brings awareness to the anti-opioid zealots who are profiting off of punishing pain patients while pretending to care about those with addiction. She also believes strongly in Harm Reduction efforts.

Each day, more than 130 people die from opioid overdoses.
Opioids are a class of drugs that include prescription pain relievers like oxycodone. They also include illegal drugs like heroin. In 2019, 1.6 million Americans had an opioid addiction. This is also known as opioid use disorder. Yet effective medications&mdash;like buprenorphine, methadone, and&nbsp;<a href="https://en.wikipedia.org/wiki/Naltrexone">naltrexone</a>&mdash;are prescribed to only a fraction of people with opioid use disorder. Patients often receive such medications in an opioid treatment program.&nbsp;<a href="https://en.wikipedia.org/wiki/Methadone">Methadone</a>, for example, can only be given in a certified treatment program. Primary care physicians can apply for a waiver to prescribe&nbsp;<a href="https://medlineplus.gov/druginfo/meds/a605002.html">buprenorphine</a>. However, less than 10% of U.S. primary care providers have a buprenorphine waiver. Given the limited number of patients that each physician can treat, involving pharmacists in opioid treatment may improve access.
The Doctor Patient Forum&rsquo;s Mission Statement is to advocate, educate, and defend the rights of patients, to protect all providers (including prescribers and pharmacists) who tirelessly work to treat their patients, and to bring awareness to the general public regarding restrictions upon medical providers. We are fighting for a return to individualized patient care instead of using guidelines and laws based on little evidence using arbitrary thresholds. Contrary to what has been said, we are not &ldquo;industry funded.&rdquo; We haven&rsquo;t taken any money from pharma. We are not being paid to promote opioids. We are simply chronic pain and illness patients who are fighting as hard as we can to effect change in this broken system where the patient&rsquo;s voice is non-existent.
For part 4 of the series, we're honored to have Ms. Bev Schechtman. Ms. Schectman is one of the founding members of Don&rsquo;t Punish Pain Rally and is the VP of The Doctor Patient Forum. She grew up in northern New Jersey, and has lived in the Raleigh area in North Carolina since 2009. Bev has been married to Randy for 18 years, and has two teenage daughters, Emma, 17, and Livvy,13. She also has a 3-year-old Aussidoodle, Griffin.
Bev has been living with Crohn&rsquo;s Disease and Psoriatic Arthritis for over two decades. She first contacted Claudia Merandi after being denied opioid medication while hospitalized for kidney stones in 2017.She was denied due to being a survivor of childhood sexual abuse. Bev is a passionate advocate for people with chronic pain and illness as well as those who have PTSD/ survived sexual assault/abuse. Bev has her B.A. in Psychology and hopes to get her M.S.W. in the near future. Bev is a voracious reader and researcher. She is passionate about understanding why pain patients are being mistreated so she can educate other patients and empower them to fight back. Bev hopes her advocacy work brings awareness to the anti-opioid zealots who are profiting off of punishing pain patients while pretending to care about those with addiction. She also believes strongly in Harm Reduction efforts.

Where's the Patient's Voice in Evidence-based Treatment & Research? | Pharmacist and Physician Opioid Collaborative

Pharmacists Answering the call | Pharmacy Podcast Nation

Ila M. Saunders, PharmD, BCOP, co-founder and leadership team member of the #PharmGradWishList interviews Ja’Miera Stuart, PharmD, #PGWL sponsee and winner of a large item crowdfunding campaign to support moving and relocation expenses to begin her PGY1 pharmacy residency.

Dr. Stuart has been interested in a career in pharmacy since high school when she began pre-pharmacy coursework. As a graduate of Florida A&M University, Dr. Stuart truly embraced the role of the pharmacist as a healthcare practitioner and ambassador. During her involvement in Student National Pharmaceutical Association, Dr. Stuart rallied and amplified the voices of underrepresented minorities. Now, Dr. Stuart began her career and continued her education as a pharmacy resident at Howard University Hospital, serving a pivotal patient population in the DC metro area.

Dr. Stuart is grateful for the generous outpouring of support from the pharmacy community who have and continue to help her achieve her goals and aspirations. She remains passionate about supporting opportunities, like those she has received, to continue diversifying pharmacy and healthcare.

To support other aspiring pharmacists, like Dr. Stuart, please follow more of her story on her instagram @morph_rx and you can find more information at pharmgradwishlist.org! 

Ila M. Saunders, PharmD, BCOP, co-founder and leadership team member of the #PharmGradWishList interviews&nbsp;Ja&rsquo;Miera Stuart, PharmD, #PGWL sponsee and winner of a large item crowdfunding campaign to support moving and relocation expenses to begin her PGY1 pharmacy residency.
Dr. Stuart has been interested in a career in pharmacy since high school when she began pre-pharmacy coursework. As a graduate of Florida A&amp;M University, Dr. Stuart truly embraced the role of the pharmacist as a healthcare practitioner and ambassador. During her involvement in Student National Pharmaceutical Association, Dr. Stuart rallied and amplified the voices of underrepresented minorities. Now, Dr. Stuart began her career and continued her education as a pharmacy resident at Howard University Hospital, serving a pivotal patient population in the DC metro area.
Dr. Stuart is grateful for the generous outpouring of support from the pharmacy community who have and continue to help her achieve her goals and aspirations. She remains passionate about supporting opportunities, like those she has received, to continue diversifying pharmacy and healthcare.
To support other aspiring pharmacists, like Dr. Stuart, please follow more of her story on her instagram @morph_rx and you can find more information at&nbsp;<a href="https://www.listennotes.com/podcasts/pharmacy-podcast/jamiera-stuart-brighter-WaVAb4oIEGp/pharmgradwishlist.org">pharmgradwishlist.org</a>!&nbsp;

Medical Marijuana & Specialty Pharmacy (Part One) - PPN Episode 521

CRx Podcast

In 2 playlist(s)

Pharmacy Podcast Network

Social links

Follow podcast

Recent clips